Literature DB >> 11009624

Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.

A R Rezaie1, S T Olson.   

Abstract

Heparin catalyzes the inhibition of factor Xa by antithrombin mainly through an allosteric activation of the serpin inhibitor, but an alternative heparin bridging mechanism has been suggested to enhance the catalysis in the presence of physiologic calcium levels due to calcium interactions with the Gla domain exposing a heparin binding exosite in factor Xa. To provide direct evidence for this bridging mechanism, we studied the heparin-catalyzed reaction of antithrombin with factor Xa, Gla-domainless factor Xa (GDFXa), and a heparin binding exosite mutant of GDFXa in the absence and presence of calcium using rapid kinetic methods. The pseudo-first-order rate constant for factor Xa inhibition by antithrombin complexed with a long-chain approximately 70-saccharide heparin showed a saturable dependence on inhibitor concentration in the presence but not in the absence of 2.5 mM Ca(2+), indicating the formation of an intermediate heparin-serpin-proteinase encounter complex with a dissociation constant of approximately 90 nM prior to formation of the stable serpin-proteinase complex with a rate constant of approximately 20 s(-1). Similar saturation kinetics were observed for the inhibition of GDFXa by the antithrombin-heparin complex, except that Ca(2+) was not required for the effect. By contrast, no Ca(2+)-dependent saturation of the inhibition rate constant was detectable over the same range of inhibitor concentrations for reactions of either a short-chain approximately 26-saccharide high-affinity heparin-antithrombin complex with factor Xa or the long-chain heparin-antithrombin complex with the heparin binding exosite mutant, GDFXa R240A. These findings suggest that binding of full-length heparin chains to an exosite of factor Xa in the presence of Ca(2+) produces a chain-length-dependent lowering of the dissociation constant for assembly of the intermediate heparin-antithrombin-factor Xa encounter complex, resulting in a several 100-fold rate enhancement by a heparin bridging mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009624     DOI: 10.1021/bi0011126

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Inhibitory properties of the P1 Tyr variant of antithrombin.

Authors:  Likui Yang; Chandrashekhara Manithody; Shabir H Qureshi; Alireza R Rezaie
Journal:  Biochemistry       Date:  2010-03-30       Impact factor: 3.162

2.  Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.

Authors:  Likui Yang; Chandrashekhara Manithody; Shabir H Qureshi; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

3.  Thr90Ser Mutation in Antithrombin is Associated with Recurrent Thrombosis in a Heterozygous Carrier.

Authors:  Yeling Lu; Bruno O Villoutreix; Indranil Biswas; Qiulan Ding; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2020-05-18       Impact factor: 5.249

4.  Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin.

Authors:  L Yang; C Manithody; S H Qureshi; A R Rezaie
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

5.  Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.

Authors:  Xin Huang; Alireza R Rezaie; George J Broze; Steven T Olson
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

6.  Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.

Authors:  Likui Yang; Qiulan Ding; Xin Huang; Steven T Olson; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-05-02       Impact factor: 3.162

7.  Simulated Thrombin Generation in the Presence of Surface-Bound Heparin and Circulating Tissue Factor.

Authors:  E Victoria Dydek; Elliot L Chaikof
Journal:  Ann Biomed Eng       Date:  2015-07-14       Impact factor: 3.934

8.  Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.

Authors:  Daniel J D Johnson; Wei Li; Ty E Adams; James A Huntington
Journal:  EMBO J       Date:  2006-04-13       Impact factor: 11.598

9.  Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.

Authors:  Alireza R Rezaie; Chandrashekhara Manithody; Likui Yang
Journal:  J Biol Chem       Date:  2005-08-03       Impact factor: 5.157

10.  A rationally designed heparin, M118, has anticoagulant activity similar to unfractionated heparin and different from Lovenox in a cell-based model of thrombin generation.

Authors:  Zoya Volovyk; Dougald M Monroe; YiWei Qi; Richard Becker; Maureane Hoffman
Journal:  J Thromb Thrombolysis       Date:  2009-08       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.